CCA
CHE icon

Column Capital Advisors’s Chemed CHE Stock Holding History

Column Capital Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23
Closed -$11.7K – 845
2022
Q4 		$11.7K Buy
+23
New +$11.2K ﹤0.01% 495
2020
Q4 		– Sell
-34
Closed -$16K – 708
2020
Q3 		$16K Sell
34
-4
-11% -$1.96K ﹤0.01% 380
2020
Q2 		$17K Buy
+38
New +$17K 0.01% 398

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Column Capital Advisors's CHE Position: Q1 2023 in Review

Column Capital Advisors sold out of Chemed (CHE) in Q1 2023, closing a stake of 23 shares — an estimated $11.7K sold.

Column Capital Advisors first reported a position in CHE in Q2 2020 and held it in 3 quarters. The position peaked at $17K in Q2 2020. 459 funds tracked by Wall St. Rank hold CHE as of Q1 2023.

  • Column Capital Advisors reported no remaining Chemed position as of Q1 2023 after selling out during the quarter.
  • Column Capital Advisors sold 23 Chemed shares in Q1 2023, an estimated $11.7K.
  • Column Capital Advisors first reported a position in Chemed in Q2 2020 and held it in 3 quarters.
  • Column Capital Advisors's Chemed position peaked at $17K in Q2 2020.
  • 459 funds tracked by Wall St. Rank held Chemed as of Q1 2023.

Based on Column Capital Advisors's 13F filing for Q1 2023, filed 9 May 2023.